Randomised clinical trial of ferric citrate hydrate on anaemia management in haemodialysis patients with hyperphosphataemia: ASTRIO study

Ferric citrate hydrate (FC) is an iron-based phosphate binder approved for hyperphosphataemia in patients with chronic kidney disease. We conducted a randomised controlled trial to evaluate the effects of FC on anaemia management in haemodialysis patients with hyperphosphataemia. We 1:1 randomised 9...

Descripción completa

Detalles Bibliográficos
Autores principales: Yokoyama, Keitaro, Fukagawa, Masafumi, Akiba, Takashi, Nakayama, Masaaki, Ito, Kyoko, Hanaki, Koji, Wolf, Myles, Hirakata, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586649/
https://www.ncbi.nlm.nih.gov/pubmed/31222044
http://dx.doi.org/10.1038/s41598-019-45335-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586649/
https://www.ncbi.nlm.nih.gov/pubmed/31222044
http://dx.doi.org/10.1038/s41598-019-45335-4

Ejemplares similares